SK Biopharm signs drug supply contract worth W99.4b

SK Biopharm disclosed Tuesday that it signed a drug supply contract with its subsidiary SK Life Science.

The contract is valued at 99.42 billion won ($70.3 million), equivalent to 14.1 percent of the company's 2025 sales.

The contract runs through Aug. 27.